Editorial
Copyright ©2010 Baishideng.
World J Gastroenterol. Jun 7, 2010; 16(21): 2579-2588
Published online Jun 7, 2010. doi: 10.3748/wjg.v16.i21.2579
Figure 2
Figure 2 Daily amount of soft drinks consumption in nonalcoholic fatty liver disease (NAFLD) patients with (n = 31) or without metabolic syndrome (n = 29) and in controls (n = 30). aP < 0.07; fatty liver without metabolic syndrome vs fatty liver with metabolic syndrome, bP < 0.001 between fatty liver subgroups and controls[14,15].